FP6 is the European Community Framework Programme for Research, Technological Development and Demonstration. It is a collection of the actions at EU level to fund and promote research.

• Attack: Adoptive engineered T cell Targeting to Activate Cancer Killing, to improve T cell mediated immunotherapy to fight a broad range of cancer
• Clinigene: European Network for the Advancement of Clinical Gene Transfer and Therapy
• Consert: consortium of European research and clinical institutions cooperating to develop gene therapy for inherited diseases
• EPI-vector consortium to develop episomal vectors as gene delivery systems for therapeutic application
• GIANT: Gene Therapy, an integrated approach to neoplastic treatment, gene therapy for the treatment of prostate cancer
• Improved precision of Cystic Fibrosis therapy, a project investigating a new approach to the gene therapy of cystic fibrosis
• Tumor-Host Genomics, a concerted effort to understand tumor-host interactions, and to identify novel therapeutic targets